Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list For clinicians treating postpartum depression and anxiety,…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Challenging the Dogma: New Evidence on Sertraline’s…
Why Clinicians Are Paying Attention to This First-in-Class D1 Antagonist Tourette syndrome remains one of the most challenging conditions in child and adolescent psychiatry—not because…
Quitting smoking is one of the most clinically meaningful steps a patient can take—but choosing the right medication can feel confusing. Wellbutrin® (bupropion) comes in…
Lumateperone is an oral, once-daily atypical antipsychotic developed by Intra‑Cellular Therapies (later acquired by Johnson & Johnson). Initially approved in the U.S. in December 2019…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published in: The Journal of Clinical Psychiatry,…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background Patients with schizophrenia face a…
Accurate measurement of prolactin is the foundation of evaluating hyperprolactinemia. Before proceeding to imaging or changing antipsychotic therapy, clinicians must ensure the elevation is real…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background Treatment-resistant depression (TRD), defined as…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📊 Poll for Clinicians: We’d love to…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: JAMA Psychiatry, September 10, 2025 (pubmed)Study:…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 2025 in BMC PsychiatryStudy: The…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 2025 in The Lancet Psychiatry…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background The challenge of treating major…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: August 18, 2025 (Topline Phase 2…
Major Depressive Disorder (MDD) continues to present treatment challenges, with many patients failing to achieve full remission despite standard antidepressant therapies. This has led researchers…
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 30, 2025, in The Journal of…
Published: June 29, 2025, in The Lancet Psychiatry Study: Pramipexole augmentation for the acute phase of treatment‑resistant, unipolar depression: a placebo‑controlled, double‑blind, randomised trial in the UK…
📌 Background Until now, esketamine nasal spray had only been approved in combination with an oral antidepressant (OAD) for treatment-resistant depression (TRD). However, esketamine recently…
📌 Background Finding safe and effective non-stimulant options for adolescents with ADHD remains a priority, especially for patients with concerns around stimulant side effects, misuse,…
📌 Background Cognitive dysfunction—including poor memory, attention, and processing speed—has emerged as a hallmark of post-COVID syndrome, especially in patients with comorbid depression. With limited…
🗓️ Context & Timeline From July 21 to 25, 2025, the U.S. Food and Drug Administration convened a 10‑member expert panel to evaluate the safety…
The treatment of acute mania in children and adolescents remains a challenging clinical decision, often requiring a balance between efficacy and tolerability. While both antipsychotics…
Patients with major depressive disorder (MDD) and prominent anxiety symptoms — often referred to as anxious depression — experience: Poorer response to antidepressant monotherapy Longer…
Time management can feel like a constant battle for individuals with ADHD. Tasks pile up, attention drifts, and the overwhelm sets in. But what if…
Negative symptoms of schizophrenia—such as blunted affect, avolition, and social withdrawal—are often resistant to standard antipsychotic treatment and remain a major unmet clinical need. Recent…
Major depressive disorder (MDD) remains one of the most challenging psychiatric conditions to treat, especially in cases that are treatment-resistant. In recent years, low dose…
Our academy’s most recent chapter has reviewed the findings from a large network meta-analysis and systematic review involving 15 randomized controlled trials and over 12,000…
One of the most important initial steps before starting a benzodiazepine taper is to determine whether the patient has developed physical dependence. The 2025 ASAM…
Motor Functional Neurological Disorders (FND) present a unique clinical challenge, often characterized by limb weakness or abnormal movements that are incongruent with known neurological diseases.…
Melancholic depression is a severe subtype of major depressive disorder (MDD), often characterized by profound biological symptoms, significant functional impairment, and poor response to psychotherapy…
Akathisia, a distressing side effect of antipsychotic medications, can significantly impact an individual’s quality of life. Characterized by an intense inner restlessness and the inability…
Post-Traumatic Stress Disorder (PTSD) remains a complex and challenging condition to treat, often requiring a combination of psychotherapy and pharmacological interventions. While sertraline has long…
❓Why Maintenance Treatment Matters? When managing bipolar disorder, much of the available research focuses on the acute treatment of depressive and manic episodes. However, long-term…
In a major regulatory update, the U.S. Food and Drug Administration (FDA) has announced the discontinuation of the Risk Evaluation and Mitigation Strategy (REMS) program…
🚀 Why is This Knowledge Important for Mental Health Professionals? Antidepressants play a critical role in treating major depressive disorder (MDD), but their impact on…
🚀 Recording available to Academy members. In our 6th monthly Insight Session, Dr. Harvinder Singh has provided a concise summary of clinically relevant findings on…
Tinnitus is defined as the conscious awareness of a sound in the absence of an external auditory stimulus. Psychotropic medications are commonly used as the…
Thank you to all the attendees for joining our live Zoom session on “Can Metformin Prevent Antipsychotic-Induced Weight Gain?” We appreciate your participation and engagement…
Treatment-resistant depression (TRD) remains a significant challenge for clinicians and patients alike, often requiring innovative strategies beyond traditional antidepressants. A groundbreaking step in addressing this…
Interpreting urine drug test results in patients prescribed opioids can be challenging. A solid understanding of opioid metabolism provides clarity and aids in clinical decision-making.…
Bipolar disorder is a complex psychiatric condition requiring effective management strategies, especially during acute manic episodes. Managing acute manic episodes requires a careful selection of…
As we approach the end of 2024, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
MONTHLY INSIGHT SESSION #5 In our 5th monthly Insight Session, Dr. Harvinder Singh has provide a concise summary of clinically relevant findings on five key…
Lithium is a widely used medication for the treatment of bipolar disorder and other mood-related psychiatric conditions. While it is highly effective, long-term use of…
Xerostomia, commonly referred to as dry mouth syndrome, is a result of reduced or absent salivary flow. Medications are common causes but systemic conditions like…
Clozapine is widely regarded as the gold standard for treatment-resistant schizophrenia, but its clinical use demands careful monitoring to maximize efficacy and minimize risks. Measuring…
Valproate is commonly prescribed in psychiatric and neurological settings for mood stabilization and seizure management. However, one potential side effect that can affect patients’ quality…
When managing epilepsy in pregnant individuals, the choice of antiepileptic drugs (AEDs) plays a critical role in optimizing maternal and fetal outcomes. A recent study…
To Our Academy Members: We are excited to announce the release of our fourth Academy Live Session! In this 15-minute session, we will cover clinically…
Tramadol, an opioid pain medication, is commonly prescribed for moderate to severe pain management, but its use alongside antidepressants can pose significant risks due to…
Antipsychotic medications are critical in managing schizophrenia and other related disorders, but they come with various side effects, one of which is the increased risk…
Bipolar disorder is a complex mental health condition characterized by recurrent episodes of mania and depression. When a person with bipolar disorder experiences acute manic…
Risperidone is a widely used second-generation antipsychotic for schizophrenia management. When prescribing risperidone, it’s crucial for clinicians to understand its dose-response curve to balance efficacy…
In a significant development for the treatment of schizophrenia, the FDA has recently approved Cobenfy, a novel medication that targets schizophrenia through non-dopaminergic pathways. This…
The treatment of acute mania in children and adolescents remains a challenging clinical decision, often requiring a balance between efficacy and tolerability. While both antipsychotics…
Transdermal selegiline is a monoamine oxidase inhibitor (MAOI) used as a treatment option for patients with treatment-resistant major depressive disorder (MDD). Why Transdermal Selegiline preferred…
When it comes to managing Major Depressive Disorder (MDD), many patients do not achieve full remission with standard antidepressant therapies alone. This is where augmentation…
When it comes to managing Major Depressive Disorder (MDD), the challenge often lies in patients who do not fully respond to first-line treatments like SSRIs…
Urine drug tests are a common tool used in clinical settings to detect the presence of amphetamines. However, interpreting these tests can be challenging due…
Delirium is an acute neuropsychiatric syndrome characterized by disturbances in attention, consciousness, and cognition. Managing delirium can be challenging, especially in patients where traditional antipsychotics…
Share This Post Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) that can significantly impact the quality of life of those…
Lamotrigine, commonly used in the management of bipolar disorder and epilepsy, has been associated with certain cardiac risks. The primary concern revolves around its potential…
Smoking cessation is a critical step toward improving overall health, and varenicline has emerged as a highly effective aid in this journey. This blog post…
Antidepressants are a cornerstone in the treatment of major depressive disorder and other mood-related conditions. However, a well-known side effect of these medications is weight…
Academy’s Monthly Bulletin: June 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Here is the summary of our posted Lectures, YouTube videos &…
In this video, we delve into the fascinating and emerging research on the potential benefits of dispensary-obtained THC for managing neuropsychiatric symptoms of dementia. Based…
Antipsychotic medications are critical in managing schizophrenia and other related disorders, but they come with various side effects, one of which is the increased risk…
Bringing a new life into the world is a momentous and joyous occasion, but it also brings with it a myriad of challenges and adjustments.…
The landscape of ADHD (Attention Deficit Hyperactivity Disorder) treatment has been notably transformed with the FDA’s recent approval of Clonidine XR, marking a significant milestone…
In the realm of modern medicine, managing drug interactions is crucial for ensuring patient safety and efficacy of treatments. Among these interactions, those between hydroxychloroquine…
In a significant advancement for those suffering from tardive dyskinesia (TD), the U.S. Food and Drug Administration (FDA) recently approved Austedo XR (extended-release deutetrabenazine). This…
Academy’s Monthly Bulletin: May 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for May 2024: Here is the summary of our…
Clinical Case Discussion: Hyponatremia Risk with Antidepressants Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical cases…
Introducing KarXT: A New Paradigm on May 1, 2024, JAMA Psychiatry published the positive results of EMERGENT-3 trials for this potential non-dopaminergic medication for schizophrenia. …
Facebook LIVE 003: Join us for our third Facebook Live[May 18 at 10:30 am PST] Facebook LIVE is a new feature for our academy students.…
/*! elementor – v3.21.0 – 25-04-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} PSYCHIATRY EDUCATION FORUM ACADEMY’S /*! elementor – v3.21.0 – 25-04-2024 */…
Clozapine, a cornerstone in the treatment of treatment-resistant schizophrenia, is known for its efficacy in patients who have not responded to other antipsychotic medications. However,…
Clinical Case Discussion: QTc Prolongation Risk with Psychotropics Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical…
Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but also takes a toll on emotions and motivation. Among the many…
PSYCHIATRY EDUCATION FORUM ACADEMY’S JOURNAL CLUB 24: 50 Years of Research on Schizophrenia: Ascendance of the Glutamatergic Synapse It is important to reflect on the…
Among the pharmacological options for MDD treatment, selegiline stands out, particularly in its transdermal form. Transdermal selegiline offers a novel approach to delivering this medication,…
In a significant stride forward in mental health treatment, the Food and Drug Administration (FDA) has recently approved Iloperidone for the management of bipolar disorder.…
On April 01, 2024: Otsuka and Click Therapeutics announced the FDA Clearance of Rejoyn™: the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of…
Academy’s Monthly Bulletin: April 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for April 2024: Here is the summary of our…
Clozapine, a second-generation antipsychotic medication, is often prescribed for individuals with schizophrenia who have not responded to other treatments. While it can be highly effective…
Major depressive disorder (MDD) remains a significant global health challenge, affecting millions of individuals and often leading to substantial impairment in daily functioning. While a…
Bipolar disorder is a chronic mood disorder associated with various mood states including mania, hypomania, depression, and mixed states. The identification and treatment of mixed…
In a groundbreaking development within the mental health sphere, MM120, an innovative therapeutic compound, has been granted the prestigious Breakthrough Therapy Designation by the U.S.…
Anorexia nervosa, a serious and potentially life-threatening eating disorder, goes far beyond its outward manifestation of extreme weight loss and food restriction. While the psychological…
Academy’s Monthly Bulletin: March 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for March 2024: Here is the summary of our…
On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of Major…
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that affects people of all ages, often presenting challenges in focus, impulsivity, and hyperactivity. Guanfacine is…
While antipsychotic medications have significantly improved the lives of individuals with severe mental health disorders, the potential for weight gain should not be overlooked. Antipsychotic…
Welcoming a new life into the world is a joyous occasion, but for mothers grappling with bipolar disorder, the decision to breastfeed becomes a nuanced…
Antidepressant-induced excessive sweating (ADIES) is reported in more than 20% of patients taking antidepressants. For this reason, the knowledge on how to identify and manage…
Clinical Case Discussion: Antidepressants in Elderly with Reduced Renal Function. Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to…
Academy’s Monthly Bulletin: Feb 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Feb 2024: Here is the summary of our…
Treatment-resistant binge eating disorder (BED) presents a challenging and complex clinical scenario, characterized by recurrent episodes of consuming large quantities of food, often rapidly and…
For individuals facing treatment-resistant Generalized Anxiety Disorder (GAD), exploring alternative medication options becomes crucial in the quest for relief. When traditional treatments such as selective…
Academy Network: Private Facebook Group Dear academy students. We have an exciting update for our students. We created this private Facebook group for our academy’s…
Antipsychotic medications are known for their potential to induce weight gain. This side effect can have significant implications for individuals’ physical health, mental well-being, and…
Caffeine is a natural stimulant that affects the central nervous system leading to increased alertness and reduced fatigue. Many people rely on caffeine to kick-start…
Academy’s Monthly Bulletin: Jan 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Jan 2024: Happy New Year to all our…
As we approach the end of 2023, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Let’s begin by answering this question first: This question is more directed toward drug-drug interactions and the role of Cytochrome P450: Atomoxetine is metabolized by…
Psilocybin is a naturally occurring psychedelic compound found in various mushroom species, commonly referred to as magic mushrooms or psilocybin mushrooms. When ingested, psilocybin is…
Clinical Case Discussion: Antidepressant of Choice with Treatment-Resistant Hypertension? [NEW UPDATE: CLINICAL CASE DISCUSSIONS]: In our Clinical Case Discussions section: Dr. Satinderpal Kaur (Family Medicine)…
Academy’s Monthly Bulletin: Dec 2023 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Dec 2023: Dear PEFA Academy Members, Here is…
PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING BIPOLAR DEPRESSION:TREATMENT UPDATE 2023 RELEASE DATE: DEC 02, 2023 Welcome Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to…
PSYCHIATRY EDUCATION FORUM ACADEMY’S JOURNAL CLUB 22: Harmonizing the Neurobiology & Treatment of Obsessive-Compulsive Disorder LECTURE SCHEDULE (1) OCD as Familial & Heritable: Do genetics…
Pregnancy and the postpartum period are profound experiences in a woman’s life, marked by numerous physical and emotional changes. For women who manage bipolar disorder…
Impulse Control Disorder (ICD) is a challenging mental health condition characterized by a chronic inability to resist impulses that can lead to harm, both to…
PSYCHIATRY EDUCATION FORUM ACADEMY’S Behavioral & Psychological Symptoms in Dementia: Treatment Update Welcome Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your…
On Sep 28, 2023: Fabre-Kramer Pharmaceuticals Announcesd the FDA Approval of EXXUA™, the Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder…
This most recent systematic review and network meta-analysis published in Lancet Psychiatry in Sep 2023 is considered the largest network meta-analysis of pharmacotherapy for bipolar…
According to this retrospective study published in JAMA Psychiatry on Sep 12, 2023: “Among older adults, more time spent in sedentary behaviors was significantly associated…
Psychiatry Education Forum Academy has a complete lecture series on PTSD management where Dr. Harvinder Singh has collaborated with Dr. David Osser. In this lecture…
Living with Generalized Anxiety Disorder (GAD) can be an uphill battle. Constantly wrestling with intrusive worries and fears can disrupt daily life and diminish one’s…
Acute manic episodes in bipolar disorder should be considered as an emergency. Managing acute manic episodes requires a careful selection of medications to help stabilize…
Lactation is a period when mothers are not only nurturing their infants physically but also emotionally. However, for mothers with severe mental health conditions, the…
On Aug 4, 2023: Biogen announced the FDA approval of ZURZUVAE™ (Zuranolone) for Women with Postpartum Depression. This is the first oral medication approved for…
According to this recent meta-analysis published in JAMA Neurology on June 26, 2023: Cholinesterase Inhibitors treatment improves psychotic symptoms in patients with Alzheimer’s disease &…
Monoamine Oxidase Inhibitors (MAOIs) have not only shown efficacy with treatment resistant depression, but are also found efficacious for the treatment of depression in the…
Urine drug tests have become a common method for detecting the presence of drugs in a person’s system. These tests are widely used in various…
PSYCHIATRY EDUCATION FORUM ACADEMY’S APATHY IN ALZHEIMER’S DISEASE BASICS & BEYOND Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but…
On July 06, 2023: FDA announced the approval of Leqembi (Lecanemab) for adult patients with early Alzheimer’s Disease or mild cognitive impairment. Psychiatry Education Forum…
Pramipexole is currently FDA-approved for Parkinson’s disease & Moderate-to-severe primary Restless Legs Syndrome but Pramipexole has promising data as an augmentation option for the management…
PSYCHIATRY EDUCATION FORUM ACADEMY’S BIPOLAR DISORDER MIXED FEATURES BASICS & BEYOND Bipolar disorder is a chronic mood disorder associated with various mood states including mania,…
Trazodone belongs to a class of antidepressant medications called serotonin antagonists and reuptake inhibitors (SARIs). Traozodone is used more for insomnia treatment compared to MDD…
On May 23, 2023: Braeburn announced that FDA has approved Brixadi, the new long-acting formulation of buprenorphine for the opioid use disorder. Now we will…
The journey of motherhood is a unique and beautiful experience, but it can also come with its own set of challenges. For mothers diagnosed with…
Antipsychotic medications play a crucial role in managing mental health conditions such as schizophrenia, bipolar disorder, and certain forms of depression. However, One potential side…
On May 11, 2023: FDA announced the approval of Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the…
FEEDING & EATING DISORDER: BINGE EATING DISORDER Lifetime prevalence estimates of DSM-IV anorexia nervosa, bulimia nervosa, and binge eating disorder are .9%, 1.5%, and 3.5%…
On April 27, 2023: Otsuka America Pharmaceutical, Inc. (Otsuka) and Lundbeck announced that FDA has approved the New Drug Application for Abilify Asimtufii. This post…
PSYCHIATRY EDUCATION FORUM ACADEMY’S ANTIPSYCHOTICS & WEIGHT GAIN: UPDATE 2023 Dear PEFA Academy Members. We are excited to announce the release of our next educational…
As medical professionals, we are often tasked with helping our patients navigate the complexities of grief and loss. Losing a loved one is a deeply painful…
Cannabis use is a highly debated topic in the medical community, and it has been linked to a range of physical and psychological problems, including…
This journal club will compare the findings of this 2014 study published in the American Journal of Psychiatry with this recent study published in Dec…
Cognitive impairment is one of the common outcomes of traumatic brain injury (TBI). TBI can cause damage to different areas of the brain, resulting in…
Anti-NMDA Receptor Encephalitis This is an autoimmune disorder in which antibodies attack NMDA (N-methyl D aspartate) type glutamate receptors at central neuronal synapses. Psychiatrists should…
ANSWER: (d) All of the above. Apply to a different application site each time a new transdermal system is applied. Do not cut the patch.…
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MANAGING BIPOLAR DISORDER IN ELDERLY Bipolar disorder can affect people of all ages, including elderly individuals. However, the symptoms…
Serotonin syndrome is considered a psychiatric emergency, characterized by an excess of serotonin in the central nervous system. If left untreated, serotonin syndrome can lead…
Nocturnal Enuresis, also known as bedwetting, is one of the underrecognized side effects from atypical antipsychotics. A comparative cohort study found that approximately one in…
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: Let’s begin by answering these questions first: Answers: Answer to Q1: (c) Nortriptyline Prefer TCAs with low affinity for…
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: INTEGRATIVE & COMPLEMENTARY PSYCHIATRY LECTURE SCHEDULE (1) St. John’s Wort for Depression Mechanism of Action: for St. John’s Wort…
Hydroxychloroquine is a medication used for the treatment of malaria, rheumatoid arthritis, and lupus erythematosus. In 2020, it gained attention as a potential treatment for…
We have no financial relationship with Amazon or any other pharmaceutical companies. Amazon Pharmacy has introduced a new feature called RxPass, a $5 prescription subscription…
We continue our lecture series “10 Augmentation Strategies for MDD” with our ninth lecture on the role of SAMe as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our eighth lecture on the role of Pramipexole as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our seventh lecture on the role of Buspirone as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our sixth lecture on the role of Stimulants as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our fifth lecture on the role of Lamotrigine as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our fourth lecture on the role of L-MethylFolate as an augmentation for major depressive…
We continue our lecture series “10 Augmentation Strategies for MDD” with our third lecture on the role of thyroid hormine as an augmentation for major…
We continue our lecture series “10 Augmentation Strategies for MDD” with our second lecture on the role of lithium as an augmentation for major depressive…
It is known that close to 50% of patients with major depressive episodes may not achieve remission after the trials of first-line antidepressants, and only…
Thank You for an Incredible 2022! Dear PEFA Academy members, As 2022 comes to a close, we wanted to take a moment to thank you…
As we approach the end of 2022, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Xerostomia, commonly referred to as dry mouth syndrome, is a result of reduced or absent salivary flow. Medications are common causes but systemic conditions like…
On Dec 16, 2022: AbbVie announced that FDA has approved Cariprazine as an adjunctive therapy to antidepressants for the treatment of major depressive disorder in…
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MAJOR DEPRESSIVE DISORDER: 10 AUGMENTATION STRATEGIES Introduction Psychiatry Education Forum Academy continues to provide high-quality, evidence-based & practice-oriented discussions…
It is well known that ischemic heart disease (IHD) can increase the risk of depression but depression can also increase the risk of IHD. It…
In 2021: Based on in-vitro studies, FDA added the following Cardiac rhythm and conduction abnormalities warning to lamotrigine package insert: Lamotrigine could cause serious arrhythmias…
Before Scrolling Down ==> Submit Your Answer First 🙂 According to this review article published in BMC Gastroenterology: Level 1 Evidence is based on ≥…
Psychiatry Education Forum’s Journal Club is an additional feature for our Academy’s members. All academy members will be automatically enrolled in this journal club. In…
Clozapine is considered a gold-standard medication for treatment-resistant schizophrenia, but close to 50% of these patients on clozapine may show poor or no response. What…
The Psychopharmacology Algorithm Project at the Harvard South Shore Program published algorithms for bipolar depression in 1999 and 2010. Here is the summary of their…
Clozapine is considered a gold-standard medication for treatment-resistant schizophrenia, but close to 40-50% of these patients on clozapine may show poor or no response. What…
Psychiatry Education Forum Academy is excited to announce the release of Academy’s 19th Journal Club discussion today: This article was published in the NEJM on…
Psychiatry Education Forum Academy is excited to announce a new feature for our academy members: Clinical Case Discussions In this section, we will discuss the…
Psychiatry Education Forum Academy is excited to announce the release of Academy’s 18th Journal Club Discussion: Anorexia Nervosa: How to Evaluate, Diagnose & Treat This…
We know that medications are not the first-line treatment for autism spectrum disorder (ASD) management but they are helpful when first-line behavioral interventions are not…
According to the International Classification of Sleep Disorders (Third Edition), Insomnia is defined as: either trouble initiating or maintaining sleep, associated with daytime consequences, and…
Delirium is one of the most commonly encountered psychiatric diagnosis in the hospital setting. Untreated delirium can have significant negative effects on patients’ morbidity and…
Psychiatry Education Forum Academy is excited to announce the following coffee club discussion: SERIOUS RASHES ASSOCIATED WITH MOOD STABILIZERS Presentation by: Dr. Satinder Pal Kaur,…
Silexan is a standardized essential oil of L. angustifolia flowers prepared by steam distillation. This is currently approved in Germany for the management of restlessness…
STEROIDS & NEUROPSYCHIATRIC ADVERSE EVENTS Neuropsychiatric Adverse Events from Non-Psychiatric Medications Patients on higher doses of steroids can present with affective, behavioral, and cognitive symptoms.…
Once you have initiated antidepressants for MDD (Major Depressive Disorder) treatment and the patient has achieved remission, how long will you continue this current antidepressant…
Watch the following short 5 minutes video from Psychiatry Education Forum’s Bipolar Disorder Update 2020 Conference. This video will briefly discuss the important laboratory workup…
Thanks to Psychiatric News for covering Psychiatry Education Forum’s Bipolar Disorder Update 2020 Conference. Here is Dr. Harvinder Singh’s interview on Bipolar Disorder Mixed Features:…
Generalized Anxiety Disorder (GAD) is a common psychiatric disorder with chronic waxing and waning course for some. Psychiatry Education Forum Academy will summarize the pharmacological…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
